Last reviewed · How we verify
NCT04556201
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
NA trial testing SOLTIVE™ Premium SuperPulsed Laser Fiber System in Kidney Stone in 450 participants. Completed in 30 May 2023.
2 February 2023
Quick facts
| Lead sponsor | Olympus Corporation of the Americas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 450 |
| Start date | 1 December 2020 |
| Primary completion | 2 February 2023 |
| Estimated completion | 30 May 2023 |
| Sites | 7 locations across Portugal, Denmark, United States |
Drugs / interventions tested
- SOLTIVE™ Premium SuperPulsed Laser Fiber System
Conditions studied
- Kidney Stone — all drugs for Kidney Stone →
- Ureteral Stone — all drugs for Ureteral Stone →
Sponsor
Olympus Corporation of the Americas
Who can join
18 and older, any sex, with Kidney Stone or Ureteral Stone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to collect real-world evidence on the performance of the SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04556201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Stone
Currently open trials in the same condition.
- NCT06944223 — Oxalate and Citrate in Humans - Response to Citrate · NA · recruiting
- NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
- NCT06576661 — Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Be · NA · recruiting
- NCT06210009 — Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease · NA · recruiting
- NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting
Other Olympus Corporation of the Americas trials
Trials by the same sponsor.
- NCT06592820 — Endoscopic Ultrasound Shear Wave Elastography Study · recruiting
- NCT04757116 — Post-Market Study to Assess iTind Safety in Comparison to UroLift · NA · recruiting
- NCT04437615 — Colorectal Polyp Clinical Decision Support Device Study · completed
- NCT04115046 — The EUS ShearWave Elastography Liver Fibrosis Study · completed
- NCT03400748 — ANET Electrosurgery Applicator Pilot Evaluation Study · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04556201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Olympus Corporation of the Americas
- Last refreshed: 1 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04556201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing